Literature DB >> 4547782

Genetic control of the immune response: in vitro stimulation of lymphocytes by (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L.

P Lonai, H O McDevitt.   

Abstract

In vitro antigen-induced tritiated thymidine uptake has been used to study the response of sensitized lymphocytes to (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L in responder and nonresponder strains of mice. The reaction is T-cell and macrophage dependent. Highly purified T cells (91% Thy 1.2 positive) are also responsive, suggesting that this in vitro lymphocyte transformation system is not B-cell dependent. Lymphocytes from high and low responder mice stimulated in vitro react as responders and nonresponders in a pattern identical to that seen with in vivo immunization. Stimulation occurs only if soluble antigen is added at physiological temperatures; antigen exposure at 4 degrees C followed by washing and incubation at 37 degrees C fails to induce lymphocyte transformation. Stimulation is specific for the immunizing antigen and does not exhibit the serologic cross-reactivity which is characteristic of these three antigens and their respective antisera. The reaction can be inhibited by anti-H-2 sera but not by anti-immunoglobulin sera. The anti-immunoglobulin sera did, however, inhibit lipopolysaccharide or pokeweed mitogen stimulation. These results suggest that the Ir-1A gene(s) are expressed in T cells, and that there are fundamental physiologic differences between T- and B-cell antigen recognition.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547782      PMCID: PMC2139625          DOI: 10.1084/jem.140.4.977

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  The thymus and circulating lymphocytes of mice.

Authors:  M J Doenhoff; A J Davies; E Leuchars; V Wallis
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-10-13

2.  Genetically determined immune responses: in vitro studies.

Authors:  M L Tyan
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

Review 3.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

4.  Genetic control of the antibody response. 3. Qualitative and quantitative characterization of the antibody response to (T,G)-A--L in CBA and C57 mice.

Authors:  H O McDevitt
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

5.  Fractionation of specific antigen-reactive cells in an in vitro system of cell-mediated immunity.

Authors:  P Lonai; H Wekerle; M Feldman
Journal:  Nat New Biol       Date:  1972-02-23

Review 6.  Specific fractionation of immunocompetent cells.

Authors:  H Wigzell
Journal:  Transplant Rev       Date:  1970

7.  Genetic control of the immune response. A selective defect in immunologic (IgG) memory in nonresponder mice.

Authors:  F C Grumet
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

8.  Genetic control of the immune response. The effect of thymectomy on the primary and secondary antibody response of mice to poly-L(tyr, glu)-poly-D, L-ala--poly-L-lys.

Authors:  G F Mitchell; F C Grumet; H O McDevitt
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

9.  The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pigs.

Authors:  D L Rosenstreich; J T Blake; A S Rosenthal
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

10.  Genetic control of the antibody response in inbred mice. Transfer of response by spleen cells and linkage to the major histocompatibility (H-2) locus.

Authors:  H O McDevitt; M L Tyan
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  16 in total

1.  The major histocompatibility complex--comparison in the mouse, man, and the rat. A review.

Authors:  T J Gill; D V Cramer; H W Kunz
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

2.  Control of proliferation and differentiation in B lymphocytes by anti-Ig antibodies and a serum-derived cofactor.

Authors:  C L Sidman; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon.

Authors:  P Lonai; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 4.  Recognition of antigens by T lymphocytes.

Authors:  H Binz; H Wigzell
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

5.  Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.

Authors:  G J Nossal; B L Pike; F L Battye
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

7.  Membrane characteristics of established human T- and B-cell lines. Cross-reactivity of human T-antigenic determinants with peripheral lymphocytes of non-human primates and the presence of MLC antigens on cultured T-cell lines.

Authors:  A Takada; H Babbitt; I Hayata; Y Takada
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

8.  Characteristics of human B cells responsive to the T-independent mitogen Branhamella catarrhalis.

Authors:  J E Calvert; A Calogeras
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

9.  Antigen-specific HLA-restricted human T-cell lines. II. A GAT-specific T-cell line restricted by a determinant carried by an HLA-DQ molecule.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  The requirement for two complementing Ir-GLphi immune response genes in the T-lymphocyte proliferative response to poly-(Glu53Lys36Phe11).

Authors:  R H Schwartz; M E Dorf; B Benacerraf; W E Paul
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.